A Phase I Study of the Human Pharmacokinetics of Elacytarabine
Phase of Trial: Phase I
Latest Information Update: 01 Mar 2014
At a glance
- Drugs Elacytarabine (Primary)
- Indications Acute myeloid leukaemia
- Focus Pharmacokinetics
- 29 Oct 2012 Planned end date changed from 1 Aug 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 29 Oct 2012 Planned number of patients changed from 15 to 45.
- 29 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.